Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record for NCT04887259 shows termination of the LAVA-051 trial. The note states this decision was a business decision and not due to safety concerns, and that the study did not progress to Phase 2.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:19.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and current status pointers; updated version to v3.2.0. - Removed the specific condition 'B-cell chronic lymphocytic leukemia' and the older version tag v3.1.0.
    Difference
    4%
    Check dated 2025-10-05T10:06:38.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Update terminology from Plasma cell myeloma to Multiple myeloma and bump revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:16:33.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No changes to pricing, stock, or other core content.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:33.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:21:29.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as resources related to various types of leukemia. Notably, several previous resources and location details have been removed.
    Difference
    10%
    Check dated 2025-08-30T11:58:15.000Z thumbnail image

Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.